The bio-tech player The Mosaic Company (MOS) has seen a mixed bag of significant events. Analysts recommend this commodity stock, with Thompson Siegel & Walmsley LLC and Davidson Investment Advisors acquiring shares. Hedge funds view MOS as a potential top Potash stock, with institutional investors holding 86% in the company. However, Barings LLC and Achmea Investment Management B.V. decreased their shares. Despite underperforming in the market on multiple occasions, the company has shown periods of outperformance. It also announced investor conference participation and a quarterly dividend of $0.21 per share. Mosaic recently saw a Q2 2024 net loss of $162 Million and reported revenue declines alongside strategic adjustments. However, its stock is seen as an ultimate value play and has experienced respectable five-year returns. It has also entered into a $1.5 billion deal to sell its Saudi JV stake to Ma’aden. Bruce Bodine will replace Joc O'Rourke as the company's new President and CEO.
The Mosaic Company MOS News Analytics from Tue, 05 May 2020 07:00:00 GMT to Sun, 15 Sep 2024 12:57:20 GMT -
Rating 0
- Innovation 0
- Rumor -8
